Back to dashboard
All PlansCoverageMedium impact

Prescription insulin drugs

Blue Cross Blue Shield of Rhode Island·RI · Endocrinology, Family Medicine, Internal Medicine +1 more·Physician
Effective date
Jan 1, 2022
We identified it
Jun 19, 2026
Days to comply

Summary

Rhode Island state law now caps insulin prescription copayments at $40 per 30-day supply, effective January 1, 2022. The $40 cap applies regardless of deductible status and covers all formulary insulin products listed in the policy.

Action Required

Action needed
Immediately: Billing team must verify that pharmacy claims processing system applies the $40 copayment cap for insulin prescriptions for Rhode Island patients. Coordinate with participating pharmacies to ensure they process insulin claims with the lower of $40, applicable copayment, or pharmacy charge. Update patient financial counseling scripts to inform Rhode Island patients of the $40 insulin copayment cap.